• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION SUPERION INDIRECT DECOMPRESSION SYSTEM; PROSTHESIS, SPINOUS PROCESS SPACER/PLATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION SUPERION INDIRECT DECOMPRESSION SYSTEM; PROSTHESIS, SPINOUS PROCESS SPACER/PLATE Back to Search Results
Model Number 101-9810
Device Problem Migration (4003)
Patient Problems Pain (1994); Discomfort (2330); No Code Available (3191)
Event Date 11/24/2020
Event Type  Injury  
Event Description
It was reported that the patient experienced discomfort and pain.Migration was confirmed via x-ray and the physician assessed that the patient's pain came back due to the migration.The patient underwent a revision procedure and the spacer was explanted.The patient is doing well postoperatively and has fully recovered.The explanted device is expected to be returned for analysis.
 
Event Description
It was reported that the patient experienced discomfort and pain.Migration was confirmed via x-ray and the physician assessed that the patients pain came back due to the migration.The patient underwent a revision procedure and the spacer was explanted.The patient is doing well postoperatively and has fully recovered.Additional information was received that the patient had unusual or contraindicated anatomy.
 
Event Description
It was reported that the patient experienced discomfort and pain.Migration was confirmed via x-ray and the physician assessed that the patient's pain came back due to the migration.The patient underwent a revision procedure and the spacer was explanted.The patient is doing well postoperatively and has fully recovered.Additional information was received that the patient had unusual or contraindicated anatomy.
 
Manufacturer Narrative
The returned spacer was analyzed and the reported event of the patient experiencing discomfort and pain due to migration was confirmed.A visual inspection revealed that the spacer had tool marks and damaged threads.The damage was likely due to the explant procedure.However, it was reported that the implant had migrated and that the patient had unusual or contraindicated anatomy.A labelling review found that migration or dislodgement of the implant is a known risk associated with the use of lumbar spine implants and associated instruments.Therefore, with all the available information, the probable cause of the patients discomfort and pain was traced to intentional off-label, unapproved, or contraindicated use due to the patients unusual or contraindicated anatomy and migration, which is a known inherent risk with use of the device.
 
Event Description
It was reported that the patient experienced discomfort and pain.Migration was confirmed via x-ray and the physician assessed that the patient's pain came back due to the migration.The patient underwent a revision procedure and the spacer was explanted.The patient is doing well postoperatively and has fully recovered.Additional information was received that the patient had unusual or contraindicated anatomy.
 
Manufacturer Narrative
Correction to block a1: patient identifier.
 
Manufacturer Narrative
Device analysis was performed on the returned indirect decompression spacer and the reported event of the patient experiencing discomfort and pain due to migration could not be confirmed.A visual inspection revealed that the spacer had tool marks and damaged threads.The damage was likely due to the explant procedure.However, it was reported that the spacer had migrated and that the patient had unusual or contraindicated anatomy.A labeling review was performed and it did not reveal any anomalies.The instructions for use (ifu) states that risks associated with lumbar spine implants and associated instruments include inability of the device/procedure to improve symptoms and/or function, and migration or dislodgement of the spacer from the original position, so that it becomes ineffective.The ifu also states that the spacer is contraindicated in patients with spinal anatomy or disease that would prevent implantation of the device or cause the device to be unstable in situ, such as instability of the lumbar spine, e.G., isthmic spondylolisthesis or degenerative spondylolisthesis greater than grade 1 (on a scale of 1 to 4) and scoliosis.Based on all available information, the reported event of the patient experiencing discomfort and pain due to device migration could not be confirmed through device analysis.A visual inspection revealed that the spacer had tool marks and damaged threads, which was likely due to the explant procedure.In addition, it was reported that the spacer had migrated and that the patient had unusual or contraindicated anatomy.However, a labelling review was performed and found that migration or dislodgement of the spacer is a known risk associated with the use of lumbar spine implants and associated instruments.
 
Event Description
It was reported that the patient experienced discomfort and pain.Migration was confirmed via x-ray and the physician assessed that the patient's pain came back due to the migration.The patient underwent a revision procedure and the spacer was explanted.The patient is doing well postoperatively and has fully recovered.Additional information was received that the patient had unusual or contraindicated anatomy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERION INDIRECT DECOMPRESSION SYSTEM
Type of Device
PROSTHESIS, SPINOUS PROCESS SPACER/PLATE
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
suite 100
valencia CA 91355
Manufacturer (Section G)
VERTIFLEX INC
2714 loker ave west
carlsbad CA 92010
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key11024515
MDR Text Key221996097
Report Number3006630150-2020-06244
Device Sequence Number1
Product Code NQO
UDI-Device Identifier00884662000536
UDI-Public00884662000536
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 11/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/09/2023
Device Model Number101-9810
Device Catalogue Number101-9810
Device Lot Number800091
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/15/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/24/2020
Initial Date FDA Received12/16/2020
Supplement Dates Manufacturer Received01/08/2021
03/09/2021
12/21/2022
10/06/2023
Supplement Dates FDA Received02/04/2021
04/06/2021
01/17/2023
11/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/10/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-